AHR and cancer: This review aims to discuss AhR’s contribution to the development of the common types of cancer that originate from three main barrier organs, including the skin, lungs, and gut, and to review the efficacy of AhR agonists and antagonists on preclinical carcinogenesis models, and address the question as to whether or not AhR modulation can be used for cancer chemoprevention.